Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?
The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment Get our breaking news email , free app or daily news podcast Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn. Zoladex will no longer be available in Australia from November, as the ABC first reported , but
Opening excerpt (first ~120 words) tap to expand
Manufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty ImagesView image in fullscreenManufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty ImagesHealthBreast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment Get our breaking news email, free app or daily news podcast Krishani DhanjiWed 10 Jun 2026 11.00 EDTSharePrefer the Guardian on GoogleThousands of women could be left without vital breast cancer and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at World news | The Guardian.
Discussion
0 commentsMore from World news | The Guardian
